Max Healthcare Institute Ltd

Max Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Max Healthcare Institute Ltd

₹ 913 -4.47%
02 Jul - close price
maxhealthcare.in BSE: 543220 NSE: MAXHEALTH
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership[1]
Max Healthcare is India’s second largest hospital chain in terms of revenue, EBITDA and market capitalisation.

Website BSE NSE
  • Market Cap ₹ 88,745 Cr.
  • Current Price ₹ 913
  • High / Low ₹ 980 / 508
  • Stock P/E 83.9
  • Book Value ₹ 86.5
  • Dividend Yield 0.11 %
  • ROCE 16.0 %
  • ROE 13.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 780% CAGR over last 5 years

Cons

  • Stock is trading at 10.6 times its book value
  • Company has a low return on equity of 13.4% over last 3 years.
  • Promoter holding has decreased over last 3 years: -46.7%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
802 1,000 1,018 976 937 1,067 1,137 1,142 1,215 1,285 1,363 1,335 1,423
634 756 779 728 729 802 818 828 874 948 976 949 1,041
Operating Profit 168 244 239 247 209 265 319 314 340 337 387 386 382
OPM % 21% 24% 23% 25% 22% 25% 28% 28% 28% 26% 28% 29% 27%
29 26 23 46 26 31 26 45 40 41 45 46 45
Interest 45 27 27 25 22 22 22 20 20 19 9 11 21
Depreciation 48 54 54 55 58 57 58 57 60 56 58 61 70
Profit before tax 104 190 182 213 154 216 265 281 301 303 366 360 336
Tax % 33% 23% 20% 11% 20% 20% -72% 21% 17% 21% 24% 20% 25%
70 147 145 190 124 173 457 222 251 240 277 289 252
EPS in Rs 0.72 1.52 1.50 1.96 1.28 1.78 4.72 2.29 2.58 2.47 2.85 2.98 2.59
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,608 1,729 1,691 1,059 2,508 3,937 4,563 5,406
1,467 1,616 1,535 965 2,101 2,986 3,322 3,914
Operating Profit 141 113 156 94 407 951 1,241 1,492
OPM % 9% 7% 9% 9% 16% 24% 27% 28%
59 65 56 48 -122 110 139 178
Interest 100 99 101 83 179 101 84 60
Depreciation 96 94 103 46 174 221 232 245
Profit before tax 5 -15 8 13 -69 739 1,064 1,365
Tax % -236% -65% 102% -1% -67% 18% -4% 23%
16 -25 -0 59 -138 605 1,104 1,058
EPS in Rs 0.29 -0.47 -0.06 1.10 -1.42 6.24 11.37 10.88
Dividend Payout % 0% 0% 0% 0% 0% 0% 9% 14%
Compounded Sales Growth
10 Years: %
5 Years: 26%
3 Years: 29%
TTM: 18%
Compounded Profit Growth
10 Years: %
5 Years: 780%
3 Years: 96%
TTM: -4%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 48%
1 Year: 54%
Return on Equity
10 Years: %
5 Years: 11%
3 Years: 13%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 537 537 537 537 966 970 971 972
Reserves 655 627 426 2,016 4,673 5,313 6,439 7,436
874 981 1,003 875 1,101 913 689 1,299
1,080 1,157 1,389 546 1,803 1,993 2,003 2,293
Total Liabilities 3,146 3,302 3,355 3,974 8,543 9,189 10,102 12,000
2,244 2,227 2,192 851 6,536 7,018 7,039 8,891
CWIP 46 38 87 28 27 151 252 445
Investments 0 0 1 2,182 1 1 1 2
856 1,036 1,075 913 1,980 2,020 2,810 2,661
Total Assets 3,146 3,302 3,355 3,974 8,543 9,189 10,102 12,000

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
156 166 89 77 118 741 1,209 1,122
-104 -124 -17 -2,641 206 -764 -1,187 -1,285
-48 -48 -74 2,353 191 -294 -289 -264
Net Cash Flow 4 -6 -2 -210 516 -317 -266 -427

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 53 59 78 33 53 36 27 31
Inventory Days 20 24 26 43 34 24 30 26
Days Payable 184 227 292 286 274 174 212 221
Cash Conversion Cycle -111 -144 -188 -210 -187 -114 -155 -164
Working Capital Days 7 -2 -136 116 -32 -13 -39 -36
ROCE % 4% 6% 4% 7% 12% 15%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
70.46% 60.91% 60.68% 50.64% 50.64% 23.80% 23.78% 23.77% 23.76% 23.76% 23.75% 23.75%
14.05% 14.23% 16.67% 14.59% 23.34% 49.27% 50.15% 51.96% 59.89% 60.39% 60.69% 57.33%
7.95% 8.70% 15.67% 17.57% 19.42% 21.16% 20.47% 19.36% 11.90% 11.40% 11.55% 14.96%
7.54% 16.16% 6.97% 17.20% 6.61% 5.76% 5.61% 4.92% 4.45% 4.45% 3.99% 3.97%
No. of Shareholders 70,65591,9371,11,8771,20,0791,05,0001,01,6591,11,7011,04,6561,11,3741,18,6351,11,3381,27,009

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls